The Qualification Examination for Specialists and Instructors in the Japanese Society of Neuroendovascular Therapy: History and Current Status
Neuroendovascular therapy is a key treatment for cerebrovascular disorders, driven by advancements in devices and techniques. The Japanese Society for Neuroendovascular Therapy (JSNET) established a certification system in 1997 to ensure operator competence and minimize complications, with the first examination in 2002. JSNET offers 2 main certifications: specialist and instructor. Specialists perform basic procedures, while instructors lead in practice, education, and research. In 2020, the mechanical thrombectomy practitioner qualification was added to promote mechanical thrombectomy. Applicants must have a JSNET membership, relevant certifications, training, and documented experience. The certification process includes rigorous written and practical examinations that now employ non-fluoroscopic models. Certification renewal every 5 years requires conference participation and a continuing education program. Public awareness and integration into stroke center designations have grown. Over 2200 specialists, including more than 500 instructors, have been certified, significantly advancing neuroendovascular therapy in Japan. JSNET aims to continue improving certification and education to maintain high standards.
Authors
- Toshiyuki Fujinaka (ORCID: https://orcid.org/0000-0002-1546-5666)
- Hirotoshi Imamura (ORCID: https://orcid.org/0000-0001-8923-7861)
- Yukiko Enomoto (ORCID: https://orcid.org/0000-0003-0019-7029)
- Yuji Matsumaru (ORCID: https://orcid.org/0000-0002-4827-8410)
- Takashi Izumi (ORCID: https://orcid.org/0000-0003-2898-3371)
- Hiro Kiyosue (ORCID: https://orcid.org/0000-0003-3305-8316)
- Tetsu Satow (ORCID: https://orcid.org/0000-0001-8136-5420)
- Hidenori Oishi (ORCID: https://orcid.org/0000-0003-1446-4888)
- Wataro Tsuruta (ORCID: https://orcid.org/0000-0001-5807-4887)
- Hitoshi Hasegawa (ORCID: https://orcid.org/0000-0003-0925-2717)
- Tomoyuki Tsumoto
- Kenji Sugiu (ORCID: https://orcid.org/0000-0001-9006-999X)
- Yasushi Matsumoto
- Hiroshi Yamagami (ORCID: https://orcid.org/0000-0001-8133-3314)
- Shigeru Miyachi (ORCID: https://orcid.org/0000-0003-2703-1379)
- Shinichi Yoshimura (ORCID: https://orcid.org/0000-0001-5633-9132)
- Toshio Higashi (ORCID: https://orcid.org/0000-0002-5143-295X)
- Akira Ishii (ORCID: https://orcid.org/0000-0003-2190-3746)
- Masaru Hirohata
- Michihiro Tanaka (ORCID: https://orcid.org/0000-0002-8208-0096)
Institutions
- Jikei University School of Medicine (JP)
- University of Tsukuba (JP)
- Okayama University (JP)
- Aichi Medical University (JP)
- Fukuoka University (JP)
- Juntendo University (JP)
- Osaka National Hospital (JP)
- Tohoku University Hospital (JP)
- Kindai University Hospital (JP)
- Kurume University Medical Center (JP)
- National Cerebral and Cardiovascular Center (JP)
- Kameda Medical Center (JP)
- SHOWA Medical University Fujigaoka Hospital (JP)
- Toranomon Hospital (JP)
- Gifu University (JP)
- Nagoya University (JP)
- Niigata University (JP)
- Hyogo University (JP)
- Kumamoto University (JP)
Publication Details
- Journal
- Journal of Neuroendovascular Therapy
- Published
- 2025-01-01
- DOI
- https://doi.org/10.5797/jnet.sr.2024-0099
- Citations
- 2
- Primary Topic
- Medical and Biological Sciences
- Type
- article
- Field-Weighted Citation Impact
- 18.58
Funders
- Stryker
- Nipro
- Otsuka Pharmaceutical
- Medtronic Japan
- Japan Society for the Promotion of Science
- Daiichi Sankyo Europe